# Liposomal Bupivacaine in Total Shoulder Arthroplasty

> **NCT02570022** · PHASE4 · COMPLETED · sponsor: **Henry Ford Health System** · enrollment: 57 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Liposomal bupivacaine
- **PROCEDURE:** Inter-scalene nerve block
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT02570022
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-05
- **Final completion:** 2016-06
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2016-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02570022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02570022, "Liposomal Bupivacaine in Total Shoulder Arthroplasty". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02570022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*